Karyopharm Therapeutics Statistics

Total Valuation

KPTI has a market cap or net worth of $231.39 million. The enterprise value is $443.75 million.

Market Cap	231.39M
Enterprise Value	443.75M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, before market open.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

KPTI has 22.66 million shares outstanding. The number of shares has increased by 72.17% in one year.

Current Share Class	22.66M
Shares Outstanding	22.66M
Shares Change (YoY)	+72.17%
Shares Change (QoQ)	+38.04%
Owned by Insiders (%)	2.91%
Owned by Institutions (%)	57.20%
Float	14.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.53
Forward PS	1.72
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.08

Current Ratio	1.08
Quick Ratio	0.97
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.78

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-40.62%
Return on Invested Capital (ROIC)	-114.56%
Return on Capital Employed (ROCE)	-596.61%
Weighted Average Cost of Capital (WACC)	10.81%
Revenue Per Employee	$662,798
Profits Per Employee	-$855,127
Employee Count	228
Asset Turnover	1.17
Inventory Turnover	31.26

Taxes

In the past 12 months, KPTI has paid $8,000 in taxes.

Income Tax	8,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +127.39% in the last 52 weeks. The beta is 0.82, so KPTI's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+127.39%
50-Day Moving Average	8.88
200-Day Moving Average	7.35
Relative Strength Index (RSI)	61.65
Average Volume (20 Days)	504,824

Short Selling Information

The latest short interest is 5.35 million, so 23.60% of the outstanding shares have been sold short.

Short Interest	5.35M
Short Previous Month	5.28M
Short % of Shares Out	23.60%
Short % of Float	36.11%
Short Ratio (days to cover)	12.00

Income Statement

In the last 12 months, KPTI had revenue of $151.12 million and -$194.97 million in losses. Loss per share was -$14.19.

Revenue	151.12M
Gross Profit	20.33M
Operating Income	-84.21M
Pretax Income	-194.96M
Net Income	-194.97M
EBITDA	-83.98M
EBIT	-84.21M
Loss Per Share	-$14.19

Full Income Statement

Balance Sheet

The company has $90.85 million in cash and $303.21 million in debt, giving a net cash position of -$212.36 million or -$9.37 per share.

Cash & Cash Equivalents	90.85M
Total Debt	303.21M
Net Cash	-212.36M
Net Cash Per Share	-$9.37
Equity (Book Value)	-265.65M
Book Value Per Share	-11.78
Working Capital	9.03M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-59.11M
Capital Expenditures	n/a
Depreciation & Amortization	230,000
Net Borrowing	27.00M
Free Cash Flow	-59.11M
FCF Per Share	-$2.61

Full Cash Flow Statement

Margins

Gross margin is 13.45%, with operating and profit margins of -55.73% and -129.02%.

Gross Margin	13.45%
Operating Margin	-55.73%
Pretax Margin	-129.01%
Profit Margin	-129.02%
EBITDA Margin	-55.57%
EBIT Margin	-55.73%
FCF Margin	n/a

Dividends & Yields

KPTI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-72.17%
Shareholder Yield	-72.17%
Earnings Yield	-84.26%
FCF Yield	-25.55%

Analyst Forecast

The average price target for KPTI is $13.50, which is 32.22% higher than the current price. The consensus rating is "Buy".

Price Target	$13.50
Price Target Difference	32.22%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (3Y)	16.34%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 26, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Feb 26, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

KPTI has an Altman Z-Score of -19.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.74
Piotroski F-Score	3